Bijuva (estradiol/progesterone) is a brand-name capsule that’s prescribed for treating certain menopausal symptoms. As with other drugs, Bijuva can cause side effects, such as cardiovascular and vision problems. Bijuva has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). For details, see the “Side effect specifics” section later....
Author: admin
Post
ChatGPT search tool vulnerable to manipulation and deception, tests show
Exclusive: Guardian testing reveals AI-powered search tools can return false or malicious results if webpages contain hidden text Nick Evershed Tue 24 Dec 2024 03.00 EST Share The Guardian’s journalism is independent. We will earn a commission if you buy something through an affiliate link. Learn more. OpenAI’s ChatGPT search tool may be open to manipulation using hidden...
Post
Scientists Destroy 99% of Cancer Cells in Lab Using Vibrating Molecules
Health25 December 2024 ByDavid Nield Illustration of a cancer cell. (Science Photo Library/Canva Pro) Scientists have discovered a remarkable way to destroy cancer cells. A study published last year found stimulating aminocyanine molecules with near-infrared light caused them to vibrate in sync, enough to break apart the membranes of cancer cells. Aminocyanine molecules are already used in bioimaging as synthetic dyes....
Post
FDA Approves Second Generic Daily GLP-1 Drug for T2D
Miriam E. Tucker December 23, 2024 0564 The US Food and Drug Administration has approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) liraglutide (Victoza, Novo Nordisk) to lower blood sugar in people aged 10 years or older with type 2 diabetes (T2D), as an adjunct to diet and exercise. The move follows...
Post
Allergic Contact Dermatitis: New Culprits
Stéphanie Lavaud December 19, 2024 023 New allergens responsible for contact dermatitis emerge regularly. During the Dermatology Days of Paris 2024 conference, Angèle Soria, MD, PhD, a dermatologist at Tenon Hospital in Paris, France, outlined four major categories driving this trend. Among them are (meth)acrylates found in nail cosmetics used in salons or do-it-yourself false nail kits...
Post
Why can I only breathe through one nostril?
People may only be able to breathe through one nostril due to congestion, allergies, a blockage, or natural changes in the nasal cycle. This is not uncommon and may get better on its own. The nasal cycle refers to the way tissue inside the nose regulates the size of the air passages, opening or narrowing...
Post
Vertex drug for cystic fibrosis wins approval
The FDA just approved Alyftrek, a once-daily medicine for a small slice of cystic fibrosis patients that carry certain mutations, including F508del. It’s a triple combination CFTR modulator that works across 31 other mutations, and outperformed Trikafta — another popular Vertex drug for cystic fibrosis — in its ability to reduce sweat chloride levels. This is the...
Post
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
Karen Weintraub USA TODAY 0:04 1:50 In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s. The drugs were first approved to treat type 2 diabetes – and that’s what the FDA said daily injections of liraglutide...
Post
Neuroscience leader reveals oxytocin’s crucial role beyond the ‘love hormone’ label
Distinguished professor Inga Neumann discusses groundbreaking social behavior research in exclusive Genomic Press InterviewReports and Proceedings Genomic Press image: Inga D. Neumann working at the Tacugama Chimpanzee Sanctuary in Sierra Leone, preparing enrichment material for chimpanzee orphans.view more Credit: Inga D. Neumann REGENSBURG, Bavaria, Germany, 24 December 2024 – In a comprehensive Genomic Press Interview, Professor Inga...
Post
TNF inhibitors prevent complications in kids with Crohn’s disease: Study recommends them as first-line therapies
by Sam Page, University of Michigan Credit: Kindel Media from Pexels Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas, a particularly debilitating complication of Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data. The resulting paper, “Early tumour necrosis factor antagonist treatment prevents perianal fistula development...